Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M, Asahina Y, Kawai-Kitahata F, Nakagawa M, Nitta S, Otani S, Nagata H, Kaneko S, Asano Y, Tsunoda T, Miyoshi M, Itsui Y, Azuma S, Kakinuma S, Tanaka Y, Iijima S, Tsuchiya K, Izumi N, Tohda S, Watanabe M. Murakawa M, et al. J Med Virol. 2017 Jul;89(7):1241-1247. doi: 10.1002/jmv.24763. Epub 2017 Feb 27. J Med Virol. 2017. PMID: 28036111
Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
Watanabe T, Sakamoto N, Nakagawa M, Kakinuma S, Itsui Y, Nishimura-Sakurai Y, Ueyama M, Funaoka Y, Kitazume A, Nitta S, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Oooka S, Watanabe M. Watanabe T, et al. Among authors: murakawa m. Antimicrob Agents Chemother. 2011 Jun;55(6):2537-45. doi: 10.1128/AAC.01780-10. Epub 2011 Mar 28. Antimicrob Agents Chemother. 2011. PMID: 21444704 Free PMC article.
Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.
Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Mishima K, Ueyama M, Onozuka I, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Watanabe M. Funaoka Y, et al. Among authors: murakawa m. J Virol. 2011 Jun;85(12):5986-94. doi: 10.1128/JVI.02583-10. Epub 2011 Apr 13. J Virol. 2011. PMID: 21490101 Free PMC article.
Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin.
Ueyama M, Nakagawa M, Sakamoto N, Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M; Ochanomizu-Liver Conference Study Group. Ueyama M, et al. Among authors: murakawa m. Antivir Ther. 2011;16(7):1081-91. doi: 10.3851/IMP1864. Antivir Ther. 2011. PMID: 22024524
Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication.
Kusano-Kitazume A, Sakamoto N, Okuno Y, Sekine-Osajima Y, Nakagawa M, Kakinuma S, Kiyohashi K, Nitta S, Murakawa M, Azuma S, Nishimura-Sakurai Y, Hagiwara M, Watanabe M. Kusano-Kitazume A, et al. Among authors: murakawa m. Antimicrob Agents Chemother. 2012 Mar;56(3):1315-23. doi: 10.1128/AAC.05764-11. Epub 2011 Dec 27. Antimicrob Agents Chemother. 2012. PMID: 22203602 Free PMC article.
Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice.
Kiyohashi K, Kakinuma S, Kamiya A, Sakamoto N, Nitta S, Yamanaka H, Yoshino K, Fujiki J, Murakawa M, Kusano-Kitazume A, Shimizu H, Okamoto R, Azuma S, Nakagawa M, Asahina Y, Tanimizu N, Kikuchi A, Nakauchi H, Watanabe M. Kiyohashi K, et al. Among authors: murakawa m. Hepatology. 2013 Jun;57(6):2502-13. doi: 10.1002/hep.26293. Epub 2013 May 14. Hepatology. 2013. PMID: 23386589
Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
Murakawa M, Asahina Y, Nakagawa M, Sakamoto N, Nitta S, Kusano-Kitazume A, Watanabe T, Kawai-Kitahata F, Otani S, Taniguchi M, Goto F, Nishimura-Sakurai Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M. Murakawa M, et al. J Gastroenterol Hepatol. 2015 Jun;30(6):1075-84. doi: 10.1111/jgh.12902. J Gastroenterol Hepatol. 2015. PMID: 25611696
Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C.
Nakagawa M, Sakamoto N, Watanabe T, Nishimura-Sakurai Y, Onozuka I, Azuma S, Kakinuma S, Nitta S, Kiyohashi K, Kusano-Kitazume A, Murakawa M, Yoshino K, Itsui Y, Tanaka Y, Mizokami M, Watanabe M; Ochanomizu-Liver Conference Study Group. Nakagawa M, et al. Among authors: murakawa m. Hepatol Int. 2013 Mar;7(1):153-61. doi: 10.1007/s12072-012-9363-6. Epub 2012 Mar 21. Hepatol Int. 2013. PMID: 26201629
Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma.
Azuma S, Asahina Y, Nishimura-Sakurai Y, Kakinuma S, Kaneko S, Nagata H, Goto F, Ootani S, Kawai-Kitahata F, Taniguchi M, Murakawa M, Watanabe T, Tasaka-Fujita M, Itsui Y, Nakagawa M, Watanabe M. Azuma S, et al. Among authors: murakawa m. Hepatol Res. 2016 Apr;46(4):312-9. doi: 10.1111/hepr.12566. Epub 2015 Sep 15. Hepatol Res. 2016. PMID: 26224167
321 results